Bachelor of Science - BS

Founder

A part of the 2024 Nucleate Bay Area Activator Cohort

IGERT NANOMEDICINE: SRIDHAR LAB (@Northeastern University)
- Facilitated development of platform technology, Contrast Enhanced Quantitative UTE (QUTE-CE) MRI, that provides insight in tracking biodistribution and delivery of chemotherapeutics
- Developed MATLAB signal processing scripts for analyzing MRI data in order to identify novel characteristics of chemotherapeutic nanocarriers
- Designed a gene-therapy, nanoparticle platform for Clustered Regularly Interspaced Palindromic Repeats (CRISPR)-Cas9 to highlight genetic vulnerabilities in HPV-induced cervical cancer

Co-op/Research Associate

Senior Computational Biologist: Assay Research & Early Development

Senior Computational Biologist

A part of the Antler VC 2024 Cohort at Austin

Founder In Residence

YAFFE LAB (@Massachusetts Institute of Technology)
- Comprehensively characterized BCR-ABL mutant subclones driving oncogenic transformation and resistance to therapy via protein sector analysis and site-directed mutagenesis
- Aided in kinase isolation of target analytes to assess functionality of novel fluorescent biomarkers used to determine enzyme activity and concentration
- Provided assistance in characterizing the human kinome in collaboration with Yale University

Co-op/Research Assistant

LANDAU LAB (@Weill Cornell Medical College/Meyer Cancer Center/New York Genome Center)
- Benchmarking of novel cfDNA library methods for alternative sequencing platforms (i.e ONT)
- Assessment of methylation along cfDNA fragments for downstream tissue-specific deconvolution via enzymatic based alternative(NEB EM-Seq) to bisulfite treatment
- Developed bioinformatic pipelines to detect somatic mutations and copy number variation in early-stage cancers in order to provide ultra-sensitive tumor fraction estimates for ctDNA
- Analyzed single-cell RNA sequencing data to investigate heterogeneity in tumor microenvironment

Research Scientist

- FOUNDING SCIENTIST at C2i Genomics (helped build company from development of initial pilot technology in Landau lab to formation of start up that subsequently raised ~$112 million)
- Development of Amazon Web Services cloud architecture for machine-learning based cancer genomics
- Analysis of ctDNA genomic features for identification of tissue of origin and tumor fraction estimation via WGS
- Management of large clinical pilot studies in collaboration with several cancer centers around the world
- Led Minimal Residual Disease assay method development for LDT & NY STATE Validation

Founding Scientist (Bioinformatics Analyst)

EPSTEIN LAB
- Built database of known microbes in order to improve feasibility of microbial identification
- Used PubMed and prior research journals to filter through a list of ~2000 novel antimicrobials
- Performed laboratory duties such as PCR, autoclave, and microbial culture

Research Assistant

Research Technician

Know about Kristofer Patel's work experience, education, bootcamps, certifications, and much more. Kristofer Patel